Samsara Investing Cash Flow decreased by 13.6% to -$54.82M in Q4 2025 compared to the prior quarter. Over 4 years (FY 2022 to FY 2026), Investing Cash Flow shows a downward trend with a 75.4% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.51M | -$3.24M | -$3.78M | -$9.50M | -$10.67M | -$6.26M | -$365.61M | -$249.31M | -$17.73M | -$16.86M | -$1.45M | -$42.65M | $3.05M | -$36.29M | -$33.87M | $0.00 | -$18.29M | -$68.16M | -$48.27M | -$54.82M |
| QoQ Change | — | +7.6% | -16.7% | -151.1% | -12.3% | +41.3% | <-999% | +31.8% | +92.9% | +4.9% | +91.4% | <-999% | +107.2% | <-999% | +6.7% | +100.0% | — | -272.7% | +29.2% | -13.6% |
| YoY Change | — | — | — | — | -204.1% | -93.1% | <-999% | <-999% | -66.2% | -169.3% | +99.6% | +82.9% | +117.2% | -115.2% | <-999% | +100.0% | -699.4% | -87.8% | -42.5% | — |